10 June 13:00 - 10 June 15:00
The Swedish Research Council and VINNOVA have announced a comprehensive and long-term investment in ‘Next-generation Biologics’. This initiative will run for eight years and the first-round call, themed ‘Development and manufacturing of biopharmaceuticals’, opens on June 10, 2016. Additional information is available here >>
Moreover, Uppsala BIO and GE Healthcare Life Sciences recently signed a two-year partnership agreement with the aim of finding new technologies and tools to further improve the development and manufacturing of biopharmaceuticals.
To outline both ventures in more detail, Uppsala BIO and Uppsala University Innovation invite researchers and companies to an information and networking meeting. Note that the Swedish Medical Products Agency will also participate, providing information about key regulatory issues and giving their views of future challenges in biopharmaceutical development and manufacture.
Programme:
13.00-13.30: Call ‘Development and manufacturing of biopharmaceuticals’ (‘Utveckling och produktion av biologiska läkemedel’), Johanna Ulfvarson, Associate Professor and Programme Director at VINNOVA
13.30-14.00: What are the technology needs for future production of biopharmaceuticals? Stefan Löfås, Science Director, GE Healthcare Bio-Sciences AB.
What does the new collaboration between GE Healthcare Life Sciences and Uppsala BIO offer? Kristin Hellman, Uppsala BIO
14.00-14.30: Regulatory aspects for new biological pharmaceuticals, Mats Welin, Senior Expert, Swedish Medical Products Agency
14.30-15.00: Coffee and mingle
Date and location:
June 10, 13.00-15.00, Navet, BioMedical Center (BMC), Uppsala
Welcome!
Uppsala BIO and Uppsala University Innovation
Registrering